Chinese assets have outgrown a “bargain basement” label as the upfront value of licensing deals involving them has increased, ...
After UCB’s Bimzelx scored five approvals just two years, the Belgian drugmaker has quickly made a blockbuster out of its ...
A handful of pharmas and celebrities are joining forces with the National Bleeding Disorders Foundation (NBDF) for a ...
While the FDA has flip-flopped on whether to review Moderna’s combination influenza and COVID-19 vaccine, it’s full speed ahead for the mRNA shot in Europe. | While the FDA has flip-flopped on whether ...
For more than a decade, CAR-T therapy has been the miracle of oncology, turning end-stage blood cancers into curable diseases ...
To further complicate clinicians’ treatment decisions, Padcev-Keytruda has become the new standard of care in first-line metastatic bladder cancer, raising the possibility that some physicians might ...
Facing vaccine pressures in multiple markets, Merck & Co. is pruning the ranks at one of its key U.S. production facilities. | In a Worker Adjustment and Retraining Notification Act alert filed this ...
As one long-running feud over the controversial generic drug carveout known as “skinny” labeling comes to a close, the United States’ top lawyer is urging the Supreme Court to reverse a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results